JP2011026234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011026234A5 JP2011026234A5 JP2009172880A JP2009172880A JP2011026234A5 JP 2011026234 A5 JP2011026234 A5 JP 2011026234A5 JP 2009172880 A JP2009172880 A JP 2009172880A JP 2009172880 A JP2009172880 A JP 2009172880A JP 2011026234 A5 JP2011026234 A5 JP 2011026234A5
- Authority
- JP
- Japan
- Prior art keywords
- pores
- wrinkle
- makeup
- partial
- pore
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
[製造方法]
(1)成分1〜18を約85℃にて均一に混合、溶解、分散させた後、室温まで冷却し、毛穴、小じわ隠し料(部分用化粧下地)を得た。
[Production method]
(1) Components 1 to 18 were uniformly mixed, dissolved and dispersed at about 85 ° C., and then cooled to room temperature to obtain pores and fine wrinkles (partial makeup base).
表1の結果から明らかなように、本発明に係わる実施例1〜8は比較例と比して、毛穴や小じわ等の皮膚表面の凹凸を目立たなくすることができるとともに、紫外線防止効果を有するという、2つの機能を兼備した毛穴、しわ隠し料(部分用化粧下地)であった。さらに詳しくは、皮膚へのつき、のびが良く、化粧持続性に優れ、長期保存しても変臭、変色、凝集、分離等の変質が生じない良好な安定性を有し、かつ安全性の高い毛穴、しわ隠し料(部分用化粧下地)であった。これに対して比較例1〜4では、紫外線防止効果が無いか、毛穴、小じわ隠し効果、使用感及び化粧持続性、安定性試験について不良であった。
As is clear from the results in Table 1, Examples 1 to 8 according to the present invention can make the unevenness of the skin surface such as pores and fine wrinkles inconspicuous and have an ultraviolet ray preventing effect as compared with the comparative example. It was a pore and wrinkle concealing agent (partial makeup base) that had two functions. More specifically, it has good stability on the skin, spreads well, has excellent makeup persistence, does not cause deterioration such as odor, discoloration, aggregation, separation, etc. even after long-term storage, and is safe. High pores, wrinkle concealment (partial makeup base). On the other hand, in Comparative Examples 1-4 , there was no ultraviolet-ray prevention effect or it was unsatisfactory about a pore, a fine wrinkle concealment effect, a feeling of use, makeup sustainability, and a stability test.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009172880A JP5562589B2 (en) | 2009-07-24 | 2009-07-24 | Cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009172880A JP5562589B2 (en) | 2009-07-24 | 2009-07-24 | Cosmetic composition |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011026234A JP2011026234A (en) | 2011-02-10 |
JP2011026234A5 true JP2011026234A5 (en) | 2012-07-12 |
JP5562589B2 JP5562589B2 (en) | 2014-07-30 |
Family
ID=43635409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009172880A Active JP5562589B2 (en) | 2009-07-24 | 2009-07-24 | Cosmetic composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5562589B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6545953B2 (en) * | 2014-12-22 | 2019-07-17 | ポーラ化成工業株式会社 | Emulsion-type external skin preparation |
JP7014417B2 (en) | 2018-05-17 | 2022-02-01 | 住江織物株式会社 | Dimmable curtains and fabrics |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19541968C2 (en) * | 1995-11-10 | 2000-01-13 | Beiersdorf Ag | Stable hydrocarbon-free cosmetic or dermatological oleogels and W / O emulsions |
JP4191314B2 (en) * | 1999-04-28 | 2008-12-03 | 株式会社コーセー | Cosmetics |
EP1136064A3 (en) * | 2000-03-21 | 2001-10-17 | Avon Products, Inc. | Method for improving the apperance of skin and topical compositions for practicing the same |
JP4495870B2 (en) * | 2001-02-19 | 2010-07-07 | 花王株式会社 | Cosmetics |
JP2002322030A (en) * | 2001-04-26 | 2002-11-08 | Kose Corp | Unevenness-correcting cosmetic |
JP2003252742A (en) * | 2002-02-28 | 2003-09-10 | Kose Corp | Melanocyte dendrite formation inhibitor and skin care preparation containing the same |
US20040228821A1 (en) * | 2003-05-16 | 2004-11-18 | The Procter & Gamble Company | Personal care products comprising active agents in a gel network |
EP1602351A1 (en) * | 2004-05-24 | 2005-12-07 | The Procter & Gamble Company | High coverage cosmetic foundation |
US8017136B2 (en) * | 2004-05-24 | 2011-09-13 | The Procter & Gamble Company | Shiny foundation |
TWI354567B (en) * | 2005-09-07 | 2011-12-21 | Kao Corp | Transparent solid cosmetic powder |
-
2009
- 2009-07-24 JP JP2009172880A patent/JP5562589B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006291180A5 (en) | ||
JP2017128738A5 (en) | ||
WO2016014741A3 (en) | Treatment compositions | |
BR112017008761A2 (en) | respirator that has corrugated filter structure | |
CA3010919A1 (en) | Treatment compositions | |
WO2015010078A3 (en) | Substituted 6,5-fused bicyclic heteroaryl compounds | |
BR112014015883A2 (en) | Monobenzoate useful as a plasticizer in plastisol compositions | |
WO2013129889A3 (en) | High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient | |
NZ631429A (en) | Porous carbon particles for use in the treatment or prevention of liver disease | |
WO2016156992A3 (en) | Powder compositions for generating cross-linked protein foams and methods of using thereof | |
JP2015509122A5 (en) | ||
WO2014120936A3 (en) | Treatments for depression and other diseases with a low dose agent | |
WO2018084627A3 (en) | Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone | |
BR112018016307A2 (en) | composition and product uses, method of combating odors and composition | |
WO2014060852A3 (en) | Compounds useful in the synthesis of benzamide compounds | |
WO2015195863A8 (en) | Hydrated 2-((4s)-6-(4-chlorophenyl)-1 -methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide | |
WO2019108021A3 (en) | Pharmaceutical composition comprising tofacitinib | |
JP2011026234A5 (en) | ||
EP3295932A3 (en) | Stable odf composition containing hardly soluble therapeutic agent | |
WO2015126129A3 (en) | Resveratrol multimer having selective inhibitory activity for hepatitis c virus genome replication, and use thereof | |
AU2018332214A8 (en) | Modified nucleoside phosphoramidites | |
WO2015066664A3 (en) | Compositions and methods for administration of an enzyme to a subject's airway | |
JP2009001575A5 (en) | ||
MX2021004332A (en) | AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF TRIFLUOROIODOMETHANE (CF3I) AND 1,1,1,3,3,3âHEXAFLUOROPROPANE (HFC-236fa). | |
JP2013213023A5 (en) |